All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.
Study of safety and efficacy of UNR844 in subjects with presbyopia.
Jun 30, 2021
Apr 10, 2023
45 Years - 55 Years (Adult)
Ophthalmic solution for topical ocular administration
Written informed consent must be obtained before any assessment is performed
Impaired near vision in each eye and when using both eyes, without any near correction
Need a certain level of near correction
Impaired distance vision in either eye, with distance correction (if any)
Severe short- or long-sightedness
Any significant medical or clinical conditions affecting vision, the eyes or general health